Claims
- 1. A compound represented by any of the following structural formulas
- 2. A pharmaceutical composition comprising an effective amount of at least one compound of claim 1 and at least one pharmaceutically acceptable carrier.
- 3. A method of inhibiting thrombin receptors comprising administering to a mammal in need of such treatment an effective amount of at least one compound of claim 1.
- 4. A method of inhibiting cannabinoid receptors comprising administering to a mammal in need of such treatment an effective amount of at least one compound of claim 1.
- 5. A method of treating thrombosis, platelet aggregation, coagulation, cancer, inflammatory diseases or respiratory diseases comprising administering to a mammal in need of such treatment an effective amount of at least one compound of claim 1.
- 6. A method of treating atherosclerosis, restenosis, hypertension, angina pectoris, arrhythmia, heart failure, myocardial infarction, glomerulonephritis, thrombotic stroke, thromboembolytic stroke, peripheral vascular diseases, cerebral ischemia, rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, diabetes, osteoporosis, renal ischemia, cerebral stroke, cerebral ischemia, nephritis, inflammatory disorders of the lungs and gastrointestinal tract, reversible airway obstruction, chronic asthma or bronchitis comprising administering to a mammal in need of such treatment an effective amount of at least one compound of claim 1.
- 7. A compound represented by the following structural formula:
- 8. A compound represented by the following structural formula
- 9. A compound represented by the following structural formula
- 10. A compound represented by the following structural formula
- 11. A compound represented by the following structural formula
- 12. A compound represented by the following structural formula
- 13. A compound represented by the following structural formula
- 14. A compound represented by the following structural formula
- 15. A compound represented by the following structural formula
- 16. A compound represented by the following structural formula
CROSS REFERENCE TO RELATED APPLICATIONS
[0001] This application is a Continuation In Part of U.S. Ser. No. 10/457,256, filed Jun. 9, 2003, which claims the benefit of U.S. Ser. No.09/880,222, filed Jun. 13, 2001, which claims the benefit of U.S. Provisional Application No. 60/211,724, filed Jun. 15, 2000.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60211724 |
Jun 2000 |
US |
Divisions (1)
|
Number |
Date |
Country |
Parent |
09880222 |
Jun 2001 |
US |
Child |
10457256 |
Jun 2003 |
US |
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
10457256 |
Jun 2003 |
US |
Child |
10671216 |
Sep 2003 |
US |